Cyclobenzaprine Hydrochloride
Product Images NDC 53489-591

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 53489-591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mutual Pharmaceutical, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cyclobenzaprine 01)

Chemical structure diagram of Cyclobenzaprine Hydrochloride showing the molecular framework including aromatic rings and attached functional groups.*

FDA Label Image

Principal Display Panel (5 mg Bottle Label)

Cyclobenzaprine Hydrochloride Tablets USP 5 mg label from Mutual Pharmaceutical Co., Inc. The label states the package contains 100 tablets. It includes storage instructions and a note that the bottle is a light-resistant container. The label also shows the NDC 53489-590-01 and the company address in Philadelphia, PA.*

FDA Label Image

Principal Display Panel (10 mg Bottle Label)

The packaging label for Cyclobenzaprine Hydrochloride Tablets USP 10 mg by Mutual Pharmaceutical Co., Inc. The label indicates a bottle containing 100 tablets. The label includes the NDC 53489-591-01, usage instructions for the bottle, lot number, expiration date, and storage instructions. The product is manufactured in Philadelphia, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.